Skip to Content
Global News Select

Cigna 1Q Revenue Grows; Per-Share Profit Rises Despite Covid-19 Costs

By Matt Grossman


Cigna Corp. logged a larger first-quarter profit on a per-share basis year over year, despite the impact of Covid-19 care costs on its U.S. medical division.

The Bloomfield, Conn.-based healthcare company Friday posted shareholders' net income of $3.30 a share, compared with $3.15 a year earlier. Total shareholders' net income was $1.16 billion, compared with $1.18 billion.

Accounting for one-time items, Cigna's adjusted profit in the first quarter was $4.73 a share. Analysts polled by FactSet were forecasting an adjusted profit of $4.37 a share

Revenue rose to $40.97 billion from $38.47 billion year over year. Analysts were expecting revenue of $40.21 billion.

Cigna's total customer relationships rose to 189.9 million, from 185.4 million, driven in part by an increase in the number of pharmacy customers, it said.

The Evernorth business, which includes coordinated and point solution health services, posted a 13% increase relative to last year's first quarter in adjusted income from operations. Adjusted income from operations in the U.S. medical business declined, however, due in part to Covid-19-related costs such as vaccines, testing and treatment, the company said.


Write to Matt Grossman at


(END) Dow Jones Newswires

May 07, 2021 06:31 ET (10:31 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.